Cormorant Asset Management LP 13D and 13G filings for Corbus Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 3:09 pm Purchase |
2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
Cormorant Asset Management LP | 2,375,000 19.500% |
350,000 (+17.28%) |
Filing |
| 2024-03-18 4:11 pm Purchase |
2024-03-08 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
Cormorant Asset Management LP | 2,025,000 19.300% |
2,025,000 (New Position) |
Filing |